http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3710055-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28c66ec90f17ecb6d5302f255aea3339
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ece86dc4e83bdecc1625390c03a76901
publicationDate 2020-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3710055-A1
titleOfInvention A method for treating or preventing idiopathic polypoidal choroidal vasculopathy (ipcv)
abstract A method for treating or preventing idiopathic polypoidal choroidal vasculopathy is provided comprising intravitreal injections of ZimuraTM (or another anti-C5 agent) and Eylea® (or another VEGF antagonist).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11103552-B2
priorityDate 2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25058195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56998918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227614219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705

Total number of triples: 49.